File:Ranitidine.svg · Wikimedia Commons · See Wikimedia Commons
ranitidine
Also known as RAN
Ranitidine, sold under the brand name Zantac among others, is a medication used to decrease stomach acid production. It is used in the treatment of peptic ulcer disease, gastroesophageal reflux disease, and Zollinger–Ellison syndrome. It can be given by mouth, injection into a muscle, or injection into a vein.
Key facts
- Drug.StdInChIKey
- VMXUWOKSQNHOCA-UHFFFAOYSA-N
- Drug.image
- Ranitidine.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 250
- Drug.image2
- File:Ranitidine-A-3D-balls.png
- Drug.image_class2
- bg-transparent
- Drug.JAN
- ranitidine hydrochloride
- Drug.tradename
- Zantac, others
- Drug.MedlinePlus
- a601106
- Drug.DailyMedID
- Ranitidine
- Drug.pregnancy_AU
- B1
- Drug.routes_of_administration
- By mouth, intravenous (IV)
- Drug.class
~23 min read
Article
25 sectionsContents
- Medical uses
- Adverse effects
- Central nervous system
- Cardiovascular
- Gastrointestinal
- Liver
- Lungs
- Blood
- Skin
- Precautions
- Disease-related concerns
- Children
- Drug tests
- <span class="anchor" id="impurities"></span>Cancer-causing due to inherent instability
- List of recalls
- Pharmacology
- Mechanism of action
- Pharmacokinetics
- Elderly
- Children
- History
- Preparations
- References
- Notes
- External links
{{Infobox drug | image = Ranitidine.svg | image_class = skin-invert-image | width = 250 | alt = | image2 = File:Ranitidine-A-3D-balls.png | image_class2 = bg-transparent | alt2 = | JAN = ranitidine hydrochloride
| pronounce = | tradename = Zantac, others | Drugs.com = | MedlinePlus = a601106 | DailyMedID = Ranitidine | pregnancy_AU = B1 | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = By mouth, intravenous (IV) | class = Histamine H2 receptor antagonist, aka H2 blocker | ATC_prefix = A02 | ATC_suffix = BA02 | ATC_supplemental = (ranitidine bismuth citrate)
Gallery (6)
Connections
Categories
Chemical articles with multiple CAS registry numbersChemical articles with multiple ChEBIsChemical articles with multiple PubChem CIDsChemicals using indexlabelsCYP3A4 inhibitorsDimethylamino compoundsDrugs developed by GSK plcDrugs developed by NovartisDrugs with non-standard legal statusECHA InfoCard ID from WikidataFuransH2 receptor antagonists